CC BY-NC-ND 4.0 · J Lab Physicians 2011; 3(01): 015-020
DOI: 10.4103/0974-2727.78555
Original Article

Pancytopenia: A Clinico Hematological Study

Gayathri B N.
Department of Pathology, SDUMC, Tamaka, Kolar,India
,
Kadam Satyanarayan Rao
Department of JJM Medical College, Davanagere, Karnataka, India
› Author Affiliations
Source of Support: Nil

ABSTRACT

Background: Pancytopenia is a relatively common hematological entity. It is a striking feature of many serious and life-threatening illnesses, ranging from simple drug-induced bone marrow hypoplasia, megaloblastic anemia to fatal bone marrow aplasias and leukemias. The severity of pancytopenia and the underlying pathology determine the management and prognosis. Thus, identification of the correct cause will help in implementing appropriate therapy.

Objectives: To study the clinical presentations in pancytopenia due to various causes; and to evaluate hematological parameters, including bone marrow aspiration.

Materials and Methods: It was a prospective study, and 104 pancytopenic patients were evaluated clinically, along with hematological parameters and bone marrow aspiration in Hematology Unit, Department of Pathology, JJMMC, Davanagere, during the period of September 2005 to September 2007.

Results: Among 104 cases studied, age of patients ranged from 2 to 80 years with a mean age of 41 years, and male predominance. Most of the patients presented with generalized weakness and fever. The commonest physical finding was pallor, followed by splenomegaly and hepatomegaly. Dimorphic anemia was the predominant blood picture. Bone marrow aspiration was conclusive in all cases. The commonest marrow finding was hypercellularity with megaloblastic erythropoiesis. The commonest cause for pancytopenia was megaloblastic anemia (74.04%), followed by aplastic anemia (18.26%).

Conclusion: The present study concludes that detailed primary hematological investigations along with bone marrow aspiration in cytopenic patients are helpful for understanding disease process and to diagnose or to rule out the causes of cytopenia. These are also helpful in planning further investigations and management.



Publication History

Article published online:
29 January 2020

© 2011.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • REFERENCES

  • 1 Kar M, Ghosh A. Pancytopenia Journal,Indian Academy of Clinical Medicine 2002;3:29-341.
  • 2 Ishtiaq O, Baqai HZ, Anwer F, Hussai N. Patterns of pancytopenia patients in a general medical ward and a proposed diagnostic approach. Available from: http://www.ayubmed.edu.pk/JAMC/PAST/16-1/osama.htm-206K-6/24/2007 .[Last accessed on 2007].
  • 3 Guinan EC, Shimamura A. Acquired and inherited aplastic anemia syndromes In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe′s Clinical Hematology. 11th ed, Philadelphia: Lippincott Williams and Wilkins; 2004. p.1397-419.
  • 4 Tilak V, Jain R. Pancytopenia-A Clinco-hematologic analysis of 77 cases. Indian J Pathol Microbiol 1992;42:399-404.
  • 5 Kumar R, Kalra SP, Kumar H, Anand AC, Madan M. Pancytopenia-A six year study. J Assoc Physicians India 2001;49:1079-81.
  • 6 Khunger JM, Arculselvi S, Sharma U, Ranga S, Talib VH. Pancytopenia-A Clinico-hematological study of 200 cases. Indian J Pathol Microbiol 2002;45:375-9.
  • 7 Knodke K, Marwah S, Buxi G, Vadav RB, Chaturvedi NK. Bone marrow examination in cases of pancytopenia. J Academy Clin Med 2001;2:55-9.
  • 8 Bhatnagar SK, Chandra J, Narayan S, Sharma S, Singh V, Dutta AK. Pancytopenia in children: Etiological profile. J Trop Pediatr 2005;51:236-9.
  • 9 Gupta V, Tripathi S, Tilak V, Bhatia BD. A study of clinico-hematological profiles of pancytopenia in children. Tropical Doct 2008;38:241-3.
  • 10 Pine M, Walter AW. Pancytopenia in Hospitalized children. A five year review. J Pediatr Hematol Oncol 2010;32:192-4.
  • 11 Terpstra WE, Lokhorst HM, Blomjour F, Meuwissen OJ, Dekker AW. Comparison of plasma cell infiltration in Bone Marrow Biopsies and Aspirates in patient with Multiple Myeloma. Br J Hematol 1992;82:46-9.